30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

Recruiting

Phase 1

Valtrex & Aspirin30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

Sponsor:

National Eye Institute (NEI)

Code:

NCT00587496

Conditions

Herpes Simplex

Eligibility Criteria

Sex: All

Age: 20+

Healthy Volunteers: Accepted

Interventions

valacyclovir hydrochloride

placebo

valacyclovir plus aspirin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-16. This information was provided to ClinicalTrials.gov by National Eye Institute (NEI) on 2008-01-07.